JLL Partners will pay a premium of approximately $123 million in cash to acquire BioClinica Inc. (Nasdaq: BIOC) lifting the stock price $1.17 to close at $7.21.
JLL Partners To Buy BioClinica
January 30, 2013 at 16:45 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.